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Interleukin 10 (IL-10) is a pleiotropic, anti-inflammatory cytokine that has a major
protective role in the intestine. Although its production by cells of the innate and
adaptive immune system has been extensively studied, its intrinsic role in intestinal
epithelial cells is poorly understood. In this study, we utilised both ATAC sequencing
and RNA sequencing to define the transcriptional response of murine enteroids to
tumour necrosis factor (TNF). We identified that the key early phase drivers of the
transcriptional response to TNF within intestinal epithelium were NFkB transcription
factor dependent. Using wild-type and Il10−/− enteroid cultures, we showed an intrinsic,
intestinal epithelium specific effect of IL-10 deficiency on TNF-induced gene
transcription, with significant downregulation of identified NFkB target genes Tnf,
Ccl20, and Cxcl10, and delayed overexpression of NFkB inhibitor encoding genes,
Nfkbia and Tnfaip3. IL-10 deficiency, or immunoblockade of IL-10 receptor, impacted
on TNF-induced endogenous NFkB activity and downstream NFkB target gene
transcription. Intestinal epithelium-derived IL-10 appears to play a crucial role as a
positive regulator of the canonical NFkB pathway, contributing to maintenance of
intestinal homeostasis. This is particularly important in the context of an inflammatory
environment and highlights the potential for future tissue-targeted IL-10
therapeutic intervention.
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Interleukin 10 (IL-10) is an anti-inflammatory cytokine that is
synthesized and secreted by lymphocytes (T and B cells),
macrophages, dendritic cells, and some epithelial cells (1, 2).
Its anti-inflammatory role has been studied extensively,
including its protective effect in innate and adaptive immune
responses (3), the central nervous system (4), in tissue fibrosis
(5), and atherosclerosis (6). The major role of IL-10 in intestinal
homeostasis was revealed by genetic intervention in mice, where
it was shown that both IL-10 deficient and IL-10 receptor
deficient mice develop spontaneous colitis (7, 8). Also, CD1d
deficiency has been shown to affect Il10 transcription in
intestinal epithelium, which was linked to increased mortality
in an oxazolone-induced murine colitis model (9). In humans,
defective IL-10/IL-10R signalling has been shown to correlate
with inflammatory bowel disease (IBD) (10, 11). Genome-wide
association studies have identified polymorphisms in IL10 and
IL10R genes, both associated with early onset of IBD, more
severe disease, and lack of response to standard treatments,
including anti-tumour necrosis factor (TNF) biologic therapy
(12, 13). Further studies using transgenic animals have revealed
that IL-10 receptor signalling in macrophages (14, 15) and T cells
(16) is critical for intestinal homeostasis and that absence
contributes to the development of intestinal inflammation.
Moreover, murine intestinal epithelial cells express functional
IL-10 receptor, that upon addition of IL-10 downregulate cell-
surface major histocompatibility complex (MHC) class II
molecule expression induced by interferon gamma (17).
IL-10 can exert its function as an anti-inflammatory cytokine
through activation of the Janus kinases/signal transducer and
activator of transcription proteins (JAK/STAT) pathway (18).
Importantly however, IL-10 also affects the nuclear factor kappa
B (NFkB) transcription factor pathway, a key signalling pathway
essential for mediation of inflammation in response to tissue
damage and infection (19). The NFkB family of transcription
factors includes five subunits, p65 or RelA, p50, c-Rel, p52, and
RelB, that may function as homo- or hetero-dimers (20). These
dimers are retained in an inactive state in the cytoplasm by
binding to a member of the family of inhibitory kB proteins
(IkBs). Upon stimulation, IkBs are degraded, and the NFkB
active dimers translocate to the nucleus to regulate transcription.
NFkB activation is essential for intestinal epithelium
homeostasis, maintaining barrier integrity, through regulation
of cellular proliferation, differentiation, and survival, and
mediating signalling and interaction between the mucosal
immune system and resident microbiota (21). Severe chronic
intestinal inflammation in mice can result from intestinal
epithelial-specific ablation of IkB kinases (IKKs), with NFkB
deficiency also leading to enhanced apoptosis of colonocytes,
impaired levels of antimicrobial peptides, and enhanced
translocation of bacteria across the mucosa (22). Important in
immune response and tolerance, it has been shown recently that
NFkB activation is necessary for differentiation of M-cells of the
follicle-associated epithelium overlying Peyer’s patches (23). In
monocytes, IL-10 can block NFkB activation either through
inhibiting the canonical pathway (p50/p65) (24) or inducingFrontiers in Immunology | www.frontiersin.org 2the nuclear translocation of the inhibitory homodimer p50/p50
(25). To date there are no studies evaluating the impact of
epithelial cell derived IL-10 on NFkB signalling dynamics in
the intestinal epithelium.
In this study, we applied both Assay for Transposase-Accessible
Chromatin (ATAC) sequencing and RNA sequencing to murine
enteroids so as to understand the transcriptional profile response to
stimulation with TNF, a key pro-inflammatory cytokine found at
high levels in the inflamed intestinal mucosa of both mouse (26)
and human (27). We validated identified target genes by qPCR in
enteroids stimulated with TNF, or with another key pro-
inflammatory stimulus of intestinal epithelium, bacterial flagellin
(28). qPCR analysis revealed for the first time that IL-10 deficient
enteroids showed a differential response to inflammatory stimuli,
affecting known targets of the canonical NFkB pathway. These
results were further validated by dynamically measuring
endogenous NFkB activation, using a lentivirus-based reporter
assay and immunoblockade approaches in TNF-stimulated
enteroid cultures.MATERIALS AND METHODS
Mice
Interleukin 10 knockout (Il10−/−) mutant mice (B6.129P2-
Il10tm1Cgn/J), backcrossed to the C57BL/6J genetic background
for several generations, were obtained from The Jackson
Laboratory (Bar Harbor ME, USA); Stock No. 002251; www.
jax.org/strain/002251) and imported via Charles River UK Ltd
(Margate, UK). Matched C57BL/6J substrain control mice were
provided by Charles River Ltd. Mice were bred and co-housed in
a specific-pathogen-free environment at the Biomedical Services
Unit, University of Liverpool. Mice were culled by rising CO2,
followed with cervical dislocation. Proximal small intestine was
dissected and transported on ice in sterile phosphate-buffered
saline (PBS) pH 7.4, for use in establishing enteroid cultures.
Ethics Statement
All animal experiments were performed in accordance with
regulations of the Home Office of the United Kingdom under
Home Office Licence (PPL: 70/8457).
Enteroid Cultures
After dissection, 1–2 cm sections of C57BL/6J or Il10−/− proximal
small intestine were cut open longitudinally and divided further
into smaller sections. Sections were flushed with ice-cold sterile
PBS pH 7.3, approximately 10 times until clear. Tissue sections
were processed in 2 mM ethylenediaminetetraacetic acid
(EDTA) chelation buffer to generate intestinal crypts, which
were then resuspended in Matrigel (Corning; Loughborough,
UK) and cultured over 7 days to generate enteroids as previously
described (29). Cultures were passaged at day 7 by mechanically
disruption through a 27G needle, resuspended in Matrigel, and
plated out again on 24-well plates. Experimental treatment of
enteroid cultures was only performed following a minimum of
one passage. Cryo-stored intestinal crypts from hTNF.LucBAC
mice, that express luciferase under the control of the human TNFJune 2021 | Volume 12 | Article 690817
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receptor (IL-10R) signalling. For IL-10R immunoblockade
experiments, enteroids were pre-treated overnight using 1 mg/
ml purified anti-mouse CD210 (IL-10R) antibody (Clone 1B1.3a)
and compared to enteroid cultures pre-treated with rat IgG1, k
isotype control antibody (Clone RTK2071) (BioLegend UK Ltd;
London, UK). For in vitro stimulation, enteroid cultures were left
untreated or stimulated with 40 ng/ml mouse recombinant TNF
(Peprotech Ltd., London, UK) or 100 ng/ml flagellin (Invivogen;




The ATAC sequencing protocol was based on the protocol of
Buenrostro et al. (31) and modified for the specific cell type, as
described below. Enteroid cultures were maintained in 24-well
plates, as described above, and they were either left unstimulated
or they were treated with 40 ng/ml TNF for 2 h (four wells per
condition). At the end of stimulation, the mediumwas removed, the
plate was transferred on ice, and 1 ml cold PBS was added in each
well. Organoids were resuspended, and the four wells were pooled
into one 15 ml Falcon tube that already contained 10 ml of cold
PBS. Cells were precipitated by centrifugation at 500 × g for 10 min,
at 4°C. The cell pellet was resuspended in 200 ml 1× Trypsin-EDTA
solution (Sigma) and incubated for 3 min, at 37°C. The reaction was
terminated by addition of 10 ml cold PBS containing 1% (w/v)
bovine serum albumin (BSA; Sigma). Cells were precipitated by
centrifugation (500 × g for 10 min, at 4°C), and the cell pellet was
resuspended in 500 ml sterile PBS. Then 50,000 cells were aliquoted
in 1.5 ml Eppendorf tubes, washed once with 1 ml cold PBS,
followed by another wash with 1 ml of resuspension buffer (10 mM
Tris/HCl pH 7.5, 10 mM NaCl, 3 mM MgCl2). The cell pellet was
resuspended in 100 ml freshly made lysis buffer (resuspension buffer
containing 0.1% (v/v) Nonidet P-40 and 0.1% (v/v) Tween-20) for 3
min on ice. The reaction was stopped by addition of 1 ml cold wash
buffer [resuspension buffer containing 0.1% (v/v) Tween-20], and
the nuclei were pelleted by centrifugation (1,000 × g for 10min, at 4°
C). The pellet was resuspended in 50 ml transposition reaction mix
(32), composing of 25 ml 2× TD Buffer (Illumina; Little Chesterford,
UK), 16.5 ml 1× PBS, 0.1% (v/v) Tween-20, 0.01% v/v Digitonin
(Promega; Southampton, UK), 1.2 ml TDE1 Tagment DNA enzyme
(Illumina) and incubated for 10min on thermomixer (1,000 rpm, at
37°C). At the end of the incubation, the genomic DNA was purified
with MinElute Reaction Cleanup Kit (Qiagen; Manchester, UK),
eluted in 10 ml BE buffer and stored at −20°C until further use. The
tagmented DNA (10 ml) was amplified by PCR to generate the
library in a 50 ml reaction mix containing 25 ml NEBNext High-
Fidelity 2×PCR Master Mix, 2.5 ml forward primer Ad1.2_502 (25
mM, 5′-aatgatacggcgaccaccgagatctacacctctctattcgtcggcagcgtc-3′) and
2.5 ml reverse indexing primer Ad2.5_705 (25 mM, 5′-
caagcagaagacggcatacgagataggagtccgtctcgtgggctcggagatgt-3′). The
PCR reactions were carried out on a qPCR LightCycler 480
(Roche; Basel, Switzerland). The PCR conditions were: 1 cycle of
72°C/5 min, 15 cycles of 98°C/30 s, 98°C/10 s, 63°C/30 s, and one
cycle of 72°C/1min. The library was purified by Agencourt AMPure
XP magnetic beads (Beckman Coulter; HighWycombe, UK), and 1Frontiers in Immunology | www.frontiersin.org 3ml of each library was assessed for quality by high sensitivity DNA
assay. Samples were analysed on the Illumina NovaSeq using SP
chemistry (Paired-end, 2 × 150 bp sequencing, generating an
estimated 325 million clusters per lane). The paired-end
sequencing data obtained from the analysis for the assay for
transposase accessible chromatin experiment, were post-processed
to remove the sequencing adapters using (33). The resulting
sequences were then aligned onto the mouse genome version
mm10.3.0.0, by using bowtie2 (version 2.3.4.3) (34) with the
following options ‘—very-sensitive’ and ‘—k 10’. The peak
identification on the alignment result were obtained using the
‘Genrich’ software with the options ‘-j’ ‘-y’ ‘-r’, ‘-e MT’. The
annotation for the identified peaks and the comparison between
samples, were performed by a custom R script using the Ensembl
genome annotation (August 2020). Bed and Bigwig format files
were uploaded for visualisation purposes on integrative genomics
viewer (IGV) application (35).
RNA Sequencing
Host transcriptome analysis was performed by RNA sequencing of
unstimulated and TNF (40 ng/ml) stimulated enteroid cultures
from C57BL/6J mice (N = 3). RNA extraction and purification from
enteroids were performed using the RNeasy mini kit (Qiagen), as
per manufacturer’s instructions. Strand-specific sequencing libraries
were prepared with the TruSeq stranded Total RNA kit (Illumina)
from 1 µg total RNA of each sample and sequenced on an Illumina
HiSeq2000 (100-nucleotide paired-end reads).
Read Mapping and Analysis of
Differential Expression
Raw reads passing the chastity filter from Illumina were first
pre-processed using cutadapt (36) and PrinSeq-lite (37)
to remove adapter and low quality sequences. The reads
were aligned to non-repeat masked version of the Mus.
musculus reference genome (GRCm38) using TopHat2 (38),
while the corresponding GTF annotation file was obtained from
the Ensembl database (Mus_musculus.GRCm38.80.gtf). The
DESeq2 package from BioConductor was used for differential
expression analysis (39). DESeq2 is based on a model using the
negative binomial distribution and uses a normalization
procedure based on sequencing depth and biological variance.
Log2 fold changes (between stimulated and unstimulated control)
and adjusted p-values (corrected for multiple testing using the
Benjamini and Hochberg method) were calculated, and genes
were selected as differentially expressed with an absolute fold-
change ≥2 and adjusted p-value of <0.05.
Cluster and Pathway Analysis
Hierarchical cluster analysis of RNA sequencing datasets was
performed using Cluster 3.0 (http://bonsai.hgc.jp/~mdehoon/
software/cluster/software.htm) (40) with nodes and correlations
identified using Java Treeview v1.59 (http://jtreeview.sourceforge.
net) (41). Identification of NFkB target genes within the sequencing
datasets was supported using gene resources available at The
Gilmore Laboratory, Cell & Molecular Biology Division, Biology
Department, Boston University, Boston MA, USA (http://www.bu.
edu/nf-kb/gene-resources/target-genes/) and additionalJune 2021 | Volume 12 | Article 690817
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analysis was performed based on the Panther classification system
that was designed to classify proteins (and their genes) in order to
facilitate high-throughput analysis [GO enrichment analysis
(geneontology.org)] (46, 47). In order to establish whether the TNF-
induced immediate–early response genes identified by RNA-
sequencing share any common transcription factors, we utilised the
freely available PASTAA tool at http://trap.molgen.mpg.de (48). This
allowed us to predict affinities of transcription factors to promoters of
those genes. A cut-off was applied at p < 0.05 for obtained
hypergeometric P-values, and this was used to generate a final list of
ranked predictions.
RNA Extraction and qPCR
RNA extraction and purification from enteroids were performed on
samples cryostored in RLT buffer using the RNeasy mini kit
(Qiagen), as per manufacturer’s instructions. Tissues isolated from
mice following intraperitoneal injection of TNF were disrupted in
RLT buffer using bead-beating in a TissueLyser II (Qiagen), and
total RNA was purified using the RNeasy mini kit. For all samples,
purified RNA was reverse transcribed using the High-Capacity
RNA-to-cDNA Kit (Applied Biosystems; Paisley, UK), and cDNA
stored at −20°C. Reactions for real time PCR (qPCR) were
performed using 96-well plates, with full reaction mix consisting
of Taqman Fast advanced master mix (Applied Biosystems),
Taqman Gene Expression Assay probes (Applied Biosystems),
and 50 ng total cDNA as per manufacturer’s instructions. All
reactions were carried out on a qPCR LightCycler 480 (Roche).
Conditions for qPCR were as follows: one cycle of: 120 s at 50°C, 20
s at 95°C; 40 cycles of 3 s at 95°C, 30 s at 60°C, and 20 s at 60°C; one
cycle at 120 s at 72°C and 30 s at 60°C. Cp values were calculated
from 2nd derivative analysis and relative quantification was
calculated using 2-DDCT method (49). Gene expression probes
were Tnf (Mm00443258_m1), Tnfaip3 (Mm00437121_m1), Nfkbia
(Mm00477798_m1), I l10 (Mm01288386_m1), I l10ra
(Mm00434151_m1), Tnip1 (Mm'01288484_m1), Tnip2
(Mm00460482_m1), Irf1 (Mm012'88580_m1), Nfkbiz
(Mm00600522_m1), Ccl20 (Mm01268'754_m1), and Cxcl10
(Mm00445235_m1). All results were normalized to the expression of
housekeeping gene Gapdh (Mm99999915_g1).
Lentiviral Transduction of Enteroids for
Assay of NFkB Activation
NFkB transcriptional activity was monitored using a lentiviral
construct (kB-NLSluc) that expresses firefly luciferase under the
control of the classical NFkB promoter. This construct is a reporter
for NFkB (5kB-Luc) in which the 5× repeat kB consensus sequence
was introduced into the luciferase vector, constructed, produce, and
used as previously described (50–52). For lentivirus transduction,
the enteroid/Matrigel mixture was solubilised in 1 ml ice-cold PBS
and further diluted with 9 ml ice-cold PBS, and the sample was
centrifuged at 600 × g for 5 min. The cell pellet was resuspended in
0.2 ml 1× trypsin and the sample was incubated for 3 min at 37°C.
Trypsinisation was terminated by addition of 10 ml PBS, and the
cells were pelleted by centrifugation at 600 × g for 5 min. The cells
were resuspended 0.1 ml Intesticult containing 10 mM Y27632Frontiers in Immunology | www.frontiersin.org 4(Sigma), and equal volume of virus was added. TransduxTM
reagent was added (200×; SBI System Biosciences; Palo Alto CA,
USA), and the mixture was spinoculated for 30 min at 800 × g at
4°C. Afterwards, the cell suspension was plated on a layer Matrigel
(2D culture) and left to grow for 72 h, with one change of medium
at 24 h post-transduction. On the day of stimulation, D-luciferine
(Biosynth AG; Staad, Switzerland) was added to the medium, to a
final concentration of 1 mM, and cultures were incubated for 20
min, followed by addition of 100 ng/ml TNF for 3 h. At the end of
stimulation, the cells were treated with 0.2 ml gentle cell dissociation
buffer (STEMCELL Technologies UK Ltd), and luminescence was
measured in luminometer (FB12 Single Tube Luminometer
(Titertek-Berthold; Harpenden, UK).
Assay of Secreted IL-10 Protein From
Murine Enteroid Cultures
Enzyme linked immunosorbent assay (ELISA) was used to
measure secreted IL-10 protein levels from murine enteroids
treated with 40 ng/ml TNF over 8 h, as per manufacturer’s
instructions (R&D Systems; Abingdon, UK).
Statistical Analysis of In Vitro and In Vivo
Experimental Datasets
Results were expressed as mean ± standard error of mean (SEM).
Statistical inferences on data were performed using non-
parametric Kruskal–Wallis test, followed by all pairwise
comparisons of all treatment means (StatsDirect v3.0.171—
StatsDirect Ltd; Birkenhead, UK). Differences were considered
statistically significant when p <0.05.RESULTS
ATAC Sequencing of Enteroids
The ATAC sequencing protocol has been developed for mouse
enteroids aiming to identify genome-wide chromatin accessible
regions, which are known to reflect active transcription (53).
Untreated enteroids were trypsinised into single cell suspension,
and 50,000 cells were used for consequent steps, as less cells
(5,000 or 10,000) did not give adequate DNA yield to create a
library. The tagmentation reaction is critical for the DNA
fragment size, because an ideal library size ranges from 200 bp
to 1 kb. Therefore, different incubation times were tested, 10, 20,
30, 60, 75, and 90 min, and the DNA fragments were accessed on
a DNA bioanalyzer. Based on data obtained we decided to
perform the tagmentation reaction for 10 min at 37°C
(Supplementary Information—Figure S1). Moreover, the
number of PCR cycles needed for the DNA library synthesis
has to be experimentally calculated. For this purpose, real time
qPCR analysis was performed and showed that 15 cycles were
sufficient to amplify the tagmented DNA without reaching the
plateau phase (Supplementary Information—Figure S1). Small
intestinal organoid cultures were either left untreated, or they
were stimulated with 40 ng/ml TNF for 2 h (N = 1 mouse per
group). At the end of the stimulation all cultures were processed
simultaneously as described in ‘Materials and Methods’, andJune 2021 | Volume 12 | Article 690817
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Coverage of the mouse genome within the samples was visualised
by IGV viewer (Figure 1A). Informatics analysis grouped the
identified peaks into three groups; 1) unstimulated only, 2) TNF-
induced only and 3) ‘common’, which refers to peaks in both the
unstimulated and stimulated sample (Figure 1B). Further
comparison revealed that the majority of the identified genes
have open chromatin in their promoter (up to 3 kb from their
transcription start site) belonged to the ‘common’ group
(Figure 1C). In the TNF-induced sample, the total peak
number was 2,954 with 918 (~31%) peaks located in the
promoter region, the known regulatory DNA element of gene
transcription. Within the promoter, 52% of the peaks appeared
in less than 1 kb from the transcription initiation site. Amongst
those genes identified, Tnf (encoding TNF) appeared to have
open chromatin within its promotor region (Figure 1D). The
genes linked to those 918 peaks were subsequently submitted for
gene ontology enrichment analysis, which identified GTPase
signalling pathways among the most significant pathways in
enteroids upon TNF treatment (Supplementary Information—
Table S1). In the ‘common’ group, we identified some known
genes involved in classical NFkB signalling pathway, such as
Nfkbia (encoding IkBa, the prototype inhibitor of NFkB),
Tnfaip3 [encoding A20, an inducible inhibitor of NFkB (54,
55)], Nfkbiz [encoding a member of the ankyrin-repeat family
with high sequence similarity to the IkB family of proteins (56)],
and NFkB target genes such as Irf1 [encoding an activator of
interferons (57)], and Ccl20 [encoding a chemokine recruited to
inflammatory sites (58)]; see Figure 1E.
RNA Sequencing of Enteroids
To further examine the transcriptional response of intestinal
epithelium to inflammatory environment, C57BL/6J enteroids
(N = 3 mice per group) were left untreated or were stimulated
with 40 ng/ml TNF for a time course up to 24 h. RNA sequencing
analysis revealed 1,141 genes that showed statistically significant
change in expression compared to untreated controls (p < 0.05)
(Figure 2A). Analysis of the early phase response, during the first
hour, showed only six genes significantly upregulated at 0.5 h post
treatment and 19 genes upregulated at 1 h, whereas no genes were
observed to be downregulated during the first hour of stimulation.
At 2 h, 296 genes were significantly elevated, with a further 213
genes identified to be significantly downregulated. Late phase
response to TNF induction saw 503 genes significantly increased
in their expression, and 412 genes observed to be downregulated. Of
the 1,141 genes identified, 213 showed ± two-fold change in
expression at one or more time points (0.5, 1, 2, and/or 24 h)
compared to unstimulated control enteroids, and our study was
further focused on them. Tnf was the most upregulated gene
in the first two time points, showing 15- and 27-fold changes,
closely followed by Tnfaip3 that showed nine- and twenty-fold
upregulation (Figures 2B, C). Overall, all six genes 0.5 h post-TNF
treatment showed significant upregulation at 1 h as well.
Following hierarchical heatmap cluster analysis, seven distinct
groups of genes were identified, see Figure 3A. In Cluster 1, genes (n
= 4) showed a pattern of expression increasing above unstimulated
control levels from 0.5 h, peaking at 2 h post-TNF stimulation,Frontiers in Immunology | www.frontiersin.org 5before decreasing in expression by 24 h; Cluster 2 genes (n = 37)
showed little increase in expression up to 1 h, with peak only at 2 h
before lowering in levels at 24 h. For Cluster 3, genes (n = 5) showed
a biphasic response, peaking initially at 1 h post TNF stimulation,
falling back to basal at 2 h, and then seen to be elevated in
expression again at 24 h. Cluster 4 contained genes (n = 24) that
displayed a steady increase in expression throughout the time-
period, with the majority plateauing at 24 h. Cluster 5 genes (n = 81)
showed relatively little change in the first hour, followed by a
consistent increase in expression from 2 to 24 h. Similarly, Cluster 6
genes (n = 57) showed a similar pattern to Cluster 5, but with some
genes dramatically elevated in expression only at 2 h continuing
through to higher levels at 24 h. Cluster 7 genes (n = 5) showed early
phase increased in expression from 0.5 h peaking at 1 h, before
dropping rapidly towards basal levels by 2 h; see Figure 3B. Data for
each gene, of their relative fold changes to controls within the
identified clusters, are provided in Supplementary Information—
Table S2.
A comparison was made between TNF-induced genes
identified as significantly upregulated (± two-fold) by RNA
sequencing (n = 296, at 2 h) and those ATAC sequencing
genes with annotated peaks within the promoter region.
Comparison of the RNAseq dataset with peaks identified in the
ATACseq ‘common’ group (i.e. shared annotated peaks
identified in unstimulated and TNF-stimulated; n = 12,446
genes, from a total of 22,016 annotated peaks) revealed 216
genes overlapping both sequencing sets. Comparison with peaks
unique only the TNF stimulated group (n = 688 genes, from 709
annotated peaks) highlighted 25 genes common to both
sequencing sets; see Supplementary Information—Figure S2.
NFkB Target Genes Induced by TNF
Gene ontology enrichment analysis of the early phase genes showed
the NFkB pathway among the most important signalling pathways
identified (Supplementary Information—Table S3). Therefore, all
significant differentially expressed genes (n = 1,141) were further
analysed against reference NFkB target gene data (Supplementary
Information—Figure S3). At 0.5 h, all six genes upregulated in
response to 40 ng/ml TNF were identified as NFkB target genes,
including Tnf, Nfkbia, Tnfaip3, Nfkbiz, Irf1, and Ccl20. It is
interesting to point out that these NFkB target genes, apart from
Ccl20, formed the early phase response to TNF, as identified in
Cluster 7 (Figure 3). The proportion of NFkB target genes
decreased over time, representing 100 (6/6), 47.4 (9/19), 13.4 (68/
509), and 10.6% (97/915) of total differentially expressed genes at
0.5, 1, 2, and 24 h post-TNF stimulation, respectively (see
Supplementary Information—Figure S3). The majority of the
NFkB target genes were upregulated upon TNF treatment, with a
smaller fraction being downregulated in the two later time points,
representing 23.5% (16/68) at 2 h, and 26.8% (26/97) at 24 h,
respectively. Among those genes identified was Il10rb, encoding the
beta subunit of the IL-10 receptor (44). Transcription factor
enrichment analysis revealed NFkB family subunits as the major
regulators of the immediate–early response genes induced by TNF
at 0.5 and 1 h. Analysis also revealed enrichment in members of the
STAT family of transcription factors, such as STAT1a/3/4/5a/6;
(see Supplementary Information—Table S4).June 2021 | Volume 12 | Article 690817
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identified from the RNA sequencing, fresh C57BL/6J enteroids
were stimulated with 40 ng/ml TNF for 1 h, with total RNA
extracted and qPCR analysis performed on reverse transcribed
cDNA. We assessed expression levels for the early phase genesFrontiers in Immunology | www.frontiersin.org 6represented within Cluster 7; Tnf, Tnfaip3, Nfkbia, Irf1, and
Nfkbiz (see Supplementary Information—Figure S4). All five
genes showed statistically significant upregulation upon TNF
treatment; the highest being Tnf and the lowest being Nfkbiz (p <





FIGURE 1 | ATAC sequencing analysis of TNF-stimulated enteroids. Enteroid cultures were left unstimulated or were stimulated with 40 ng/ml TNF for 2 h. DNA
isolated from these cultures was further processed, amplified by PCR, and DNA sequencing followed by informatics analysis. (A) Genome coverage in both
experimental conditions analysed, and (B) charts illustrating the percentage of annotated peaks identified within different genomic regions, with percentages shown
to one decimal place. Informatics analysis grouped the peaks into three groups; 1) unstimulated only (− TNF), 2) TNF-induced only (+ TNF) and 3) ‘common’, which
refers to peaks in both the unstimulated and stimulated sample. (C) Venn diagram comparing the unstimulated and stimulated samples, illustrating the number of
identified genes as having open chromatin in their promotor. Venn diagram software from Ghent University, freely available at http://bioinformatics.psb.ugent.be/
webtools/Venn/. (D) Tnf locus and peak annotation in unstimulated and stimulated conditions. (E). Five classical NFkB signaling pathway genes identified by ATAC-
sequencing as having open chromatin loci. Green asterisks indicate annotated peaks unique to the stimulated sample. Red asterisks highlight the peaks ‘common’
to both conditions.June 2021 | Volume 12 | Article 690817
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less potent activator of enteroids than TNF, similar expression
profiles for all five genes studied were seen (Supplementary
Information—Figure S4).
NFkB Target Genes Are Differentially
Expressed in TNF- and Flagellin-
Stimulated Enteroids Deficient in
Interleukin 10
To examine whether IL-10 deficiency impacted on intestinal
epithelium-specific expression of NFkB target genes, enteroids
from both C57BL/6J and Il10−/− mice were either leftFrontiers in Immunology | www.frontiersin.org 7unstimulated or they were stimulated with 40 ng/ml TNF, over 8
h. At rest, Tnf mRNA levels were five-fold higher in Il10−/−
enteroids compared to controls (p < 0.05, Kruskal–Wallis test,
N = 3–4 mice). Absolute levels of all other genes tested were low,
withNfkbia, Nfkbiz, and Irf in Il10−/− enteroids significantly reduced
(all p < 0.05); see Supplementary Information—Figure S5. Notably,
TNF induced expression of its own gene in both genotypes, with the
response markedly reduced in IL-10 deficient enteroids (45.3%
reduction at peak time 4 h; p < 0.05, N = 3–4 mice), Figure 4A.
Similarly, reduced response to TNF was also observed for Irf1,
Nfkbiz, and Ccl20, the latter of which was almost undetectable in
Il10−/− enteroids. Attenuated early phase response to TNF (1 h) inA
B
C
FIGURE 2 | Gene expression changes in TNF-stimulated C57BL/6J enteroids as assessed by RNA sequencing. Enteroid cultures were left unstimulated or
stimulated with 40 ng/ml TNF for 0.5, 1, 2, and 24 h. Total RNA was isolated, sequencing was performed, followed by informatics analysis. (A) Total number of
differentially expressed genes across all time points sampled and fold change in expression of specific genes at (B) 0.5, and (C) 1 h post-TNF treatment (N = 3
mice). All genes presented were identified as being significantly upregulated; p < 0.05 (calculated based on log2 fold changes between stimulated and unstimulated
controls, and corrected for multiple testing using the Benjamini and Hochberg method).June 2021 | Volume 12 | Article 690817
Papoutsopoulou et al. Epithelial IL-10 Positively Regulates NFkBIl10−/− enteroids was also seen for bothNfkbia and Tnfaip3, although
their mRNA levels were much higher at later time points (4–8 h)
than those of the wild-type (Figure 4A). Parallel cultures of 100
ng/ml flagellin-treated Il10−/− enteroids (N = 3–4 mice) showedFrontiers in Immunology | www.frontiersin.org 8similar defect in Tnf and Ccl20 expression (Figure 4B), albeit
expression levels were considerably lower compared to those
seen following TNF stimulation. Flagellin-induced Nfkbia and
Tnfaip3 early phase expression was also suppressed in theA B
FIGURE 3 | RNA sequencing cluster analysis of TNF-induced enteroids. (A) Heatmap and dendrogram of significantly altered genes (± two-fold change) at time
points 0.5, 1, 2, and 24 h post-treatment with 40 ng/ml TNF compared to unstimulated controls. (B) Cluster correlation analysis identified seven gene groups
(Clusters 1–7), with each graph illustrating the dynamic expression profile of individual genes compared to unstimulated controls (0 h). Genes (red lines) are plotted
alongside the trend-line (dotted black line) for that cluster so that conformity to the trend can be observed. Data of the relative fold changes to controls for each gene
within the clusters are provided in Supplementary Information—Table S2.June 2021 | Volume 12 | Article 690817
Papoutsopoulou et al. Epithelial IL-10 Positively Regulates NFkBabsence of IL-10, with delayed elevation of expression at later
time points (Figure 4B). Similarly, Il10−/− enteroids show
attenuated expression of early phase genes Irf1 and Nfkbiz
upon flagellin stimulation but markedly higher expression ≥2 h
post-treatment. In addition, Tnip1 and Tnip2, genes encoding
ABIN proteins reported to interact with A20 and regulate the
NFkB pathway (59, 60) were also examined (Supplementary
Information—Figure S6). At rest Tnip1 levels were significantly
lower in IL-10 deficient enteroids (p < 0.05). Only Tnip1 was
significantly induced by TNF, and to a much lesser extent by
flagellin, compared to unstimulated controls. However, both
Tnip1 and Tnip2 levels were elevated by both stimuli in Il10−/−
enteroids compared to C57BL/6J controls, particularly at later
time points.
IL-10 Expression in TNF-Induced
C57BL/6J Enteroids
In response to 40 ng/ml TNF treatment, Il10 mRNA levels in
C57BL/6J enteroid cultures were seen to rapidly peak at 1 h (44.9 ±
16.9-fold increase; p < 0.001, Kruskal–Wallis test; N = 6 mice), with
a return to resting levels by 4 h (Figure 5A). TNF-induced secretion
of IL-10 protein to culture medium was observed at 2 h, with levels
at 8 h reaching 47.2 ± 1.4 pg/ml (mean ± SEM) compared to
untreated controls; p < 0.05; N = 6 mice (Figure 5B).
The IL-10/IL-10R Axis Impacts on
Endogenous NFkB Activation and NFkB
Target Gene Transcription
To examine the impact of IL-10 deficiency on NFkB activity,
enteroids were transduced with lentivirus that expresses
luciferase under the promoter of the p50/65 heterodimer.
Transduced C57BL/6J enteroids stimulated for 3 h with 100
ng/ml TNF, showed a 2.1-fold increase in NFkB-regulated
luciferase activity compared to unstimulated controls (p < 0.05;
Kruskal–Wallis test; N = 3 mice), whereas no response to
treatment was observed in IL-10 deficient enteroids
(Figure 6A). In an additional experiment performed using
hTNF.LucBAC enteroids expressing luciferase under the
control of the human TNF promoter, 100 ng/ml TNF for 2 h
induced a 2.7-fold increase in signal over 2 h compared to
unstimulated controls (p < 0.05; Kruskal–Wallis test; N = 3–4
mice). Pre-treatment of C57BL/6J enteroids overnight with 1 mg/
ml anti-mouse IL-10R antibody significantly blocked TNF-
induced luciferase activity (p < 0.05). No such suppression
observed using the isotype control (Figure 6B).
At the level of gene transcription, immunoblockade of IL-10R
signalling in enteroids was observed to markedly suppress TNF-
induced expression of early response NFkB target genes Tnf,
(39.0% reduction in transcription) and Tnfaip3 (65.1%
reduction); both p < 0.05 compared to enteroids stimulated
with TNF alone, and p < 0.01 compared to TNF plus isotype
control antibody; N = 3 mice. No significant suppression of TNF-
induced increase in Tnf or Tnfaip3 transcription was observed
using the isotype control antibody; see Figure 6C.
Similarly, C–X–C motif chemokine 10 (Cxcl10), a key late
response NFkB target gene identified within the RNAFrontiers in Immunology | www.frontiersin.org 9sequencing data set as being significantly induced by TNF, was
also shown to be regulated by the IL-10/IL-10R axis in enteroid
cultures. At rest, Cxcl10 mRNA levels were observed to be 4.35
(± 0.77) fold higher in Il10−/− enteroids compared to controls
(p < 0.01, Kruskal–Wallis test, N = 4 mice); see Figure 7A. TNF,
at 40 ng/ml, increased the expression of Cxcl10measured through
to 8 h, with the response seen to be significantly reduced in
enteroids deficient in IL-10 (67.8% reduction at peak time 8 h;
p < 0.001, N = 3–4 mice); see Figure 7B. Immunoblockade of
IL-10R in C57BL/6J enteroids was also seen to markedly suppress
TNF-induced increase in Cxcl10mRNA levels by 41.2%; p < 0.01,
N = 3 mice (Figure 7C). However, whilst this was significant
compared to TNF treatment alone, it was not significant when
compared to TNF plus isotype control antibody (p = 0.18), which
was also seen to significantly reduce Cxcl10 mRNA levels by
21.7% compared to TNF alone (p < 0.05) (Figure 7C).DISCUSSION
In vitro cultures of intestinal crypt stem cell-derived epithelial
organoids are now widely used for studies on the physiological
responses of the intestinal epithelium (61, 62). These cultures can
be maintained long-term due to the presence of stem cells that
have the ability, under specific stimuli, to give rise to epithelial
cell subpopulations with specific functions (63, 64). Moreover,
mammalian intestinal epithelial organoids have been shown to
have epigenetic signatures with striking similarities to the ones of
the original tissue (65), offering advantages to research
transcriptional regulation within the intestinal epithelium. One
such approach is ATAC sequencing, a genome-wide open
chromatin analysis that reflects active transcription and
epigenetic modifications, with recent reports of its use with
human intestinal organoids (66). Here, we have established an
ATAC sequencing protocol for use with murine enteroids in
order to study the transcriptional effects of TNF. Our analysis
revealed that a significant number of genes following stimulation
with TNF were seen to have open chromatin, particularly in their
promotor regions, including Tnf and Btg2 (B cell translocation
gene 2), both known to be important in the intestinal epithelium
(67, 68). We also identified other key genes that had open
chromatin at resting levels in enteroids, with additional peaks
seen upon TNF stimulation, including genes associated with the
NFkB signalling pathway and downstream NFkB target genes
(60, 69). Pathway enrichment analysis of the promoter region-
related peaks showed that the integrin signalling pathway was
also highly represented and known to regulate apoptotic
processes in the intestinal epithelium (70).
For further in-depth analysis of the transcriptional effects of
TNF, we performed quantitative RNA sequencing on enteroid
cultures stimulated for up to 24 h. Analysis here identified over
1,000 differentially expressed genes throughout the time course,
with the majority being upregulated compared to the
unstimulated controls, especially within the first two sampling
time points at 0.5 and 1 h. Cluster analysis assigned genes to
seven groups based on their expression profile, from early phaseJune 2021 | Volume 12 | Article 690817
Papoutsopoulou et al. Epithelial IL-10 Positively Regulates NFkBgenes peaking at 1 h (Cluster 7), to late response genes that peak
in expression at 2 h, reaching a plateau through to 24 h (Cluster
4), or continuing to increase in their expression (Clusters 5 and
6). Gene ontology enrichment analysis performed on all
differentially regulated genes indicated that the most
prominent pathway enriched was the NFkB transcriptionFrontiers in Immunology | www.frontiersin.org 10factor pathway. A strikingly high proportion of NFkB target
genes was identified in the early time points, 100 and 47% at 0.5
and 1 h, respectively. This was further supported by transcription
factor enrichment analysis, which also revealed NFkB family
subunits as the major regulators of the immediate–early response
genes induced by TNF. Our data support previous observations,A B
FIGURE 4 | Defective expression of the early response NFkB target genes in interleukin 10 deficient enteroids. Enteroid cultures from C57BL/6J and Il10−/− mice
were left unstimulated or stimulated with either (A) 40 ng/ml TNF, or (B) 100 ng/ml flagellin, for up to 8 h. qPCR analysis of early response NFkB target genes Tnf,
Tnfaip3, Nfkbia, Ccl20, Irf1, and Nfkbiz was performed. Data is presented as mean ± SEM; N = 3–4 mice.June 2021 | Volume 12 | Article 690817
Papoutsopoulou et al. Epithelial IL-10 Positively Regulates NFkBthat TNF impacts on intestinal homeostasis by activating NFkB
signalling and that this can promote cell survival or cell death,
dependent on duration of the stimulation and/or cellular
condition (71, 72). Amongst those early phase NFkB targets
identified by RNA sequencing, were genes we had already shown
as having open chromatin loci using ATAC sequencing. One
example was Tnf, a gene whose promoter region contains a
known NFkB binding motif which upon transcription factor
binding, results in positive autoregulation of its own
transcription (73). We showed other TNF-induced early
response genes (e.g. Tnfaip3, Nfkbia and Irf1) to have open
chromatin under resting conditions. Previous RNA sequencing
studies in murine enteroids also support these observations for
Tnfaip3 (74, 75), Nfkbia (74, 75), and Irf1 (74) expression under
resting conditions. For Nfkbiz and Ccl20 however, we found
these genes to have open chromatin evident at rest but with little
detectable expression, until that is, following exposure to TNF.Frontiers in Immunology | www.frontiersin.org 11Other studies also support negligible levels of expression of these
two genes in enteroids under basal conditions (74, 75). This
suggests that these might be considered as ‘poised’ genes (i.e.
genes whose promotors are preloaded with poised polymerase II
to prepare for rapid activation (76, 77). Further studies to
examine these loci at the chromatin level would be necessary
to support this hypothesis. In addition, we noted that both
Tnfaip3 and Tnip1, encoding for A20 and ABIN1 respectively,
appeared in both high-throughput sequencing approaches.
These two proteins have been shown to be upregulated by
TNF and synergistically prevent intestinal inflammation by
restricting intestinal epithelial death and preserving tissue
integrity (78). One of the downregulated genes identified was
Il10rb, encoding the signalling subunit of the IL-10 receptor
(3, 44).
It is well established that in immune cells, IL-10 can inhibit
NFkB activation and its subsequent proinflammatory action (3,
24, 25), and this was further supported recently by RNA
sequencing analysis of LPS-induced Il10 deficient macrophages
(79). Little is known though, about the function of the intestinal
epithelium-produced IL-10, which was the focus of our study
here. Previous in vivo studies have suggested a protective role for
IL-10 in preventing intestinal inflammation, with Il10rb−/− mice
developing spontaneous colitis (3). In addition, a comparative
study of IBD and a piroxicam-accelerated colitis Il10−/− model
shows a high degree of similarity in their colon transcriptional
signatures (80). In these in vivo models though, it is almost
impossible to separate autocrine versus paracrine effects and
understand how each individual cell type functions within the
immune and epithelial cell compartments.
However, using our in vitro enteroid culture system, we were
able to perform experiments to monitor the dynamic transcriptional
response of TNF in both wild-type and Il10 null enteroids. We were
also able to examine the action of bacterial flagellin, known to
activate the NFkB pathway downstream of TLR5 (81) and play an
important role in the development and progression of intestinal
inflammation (82). Quantitative qPCR validated our RNA
sequencing data, and clearly showed an intrinsic, intestinal
epithelium-specific effect of IL-10 deficiency on gene
transcription. This was also confirmed following immunoblockade
of IL-10R in wild-type enteroids. Flagellin also significantly induced
expression of Tnf, Nfkbia, Tnfaip3, and Ccl20 in agreement with
previous RNA sequencing data from flagellin-induced of murine
organoids (74). Absence of IL-10 attenuated both TNF- and
flagellin-induced expression of the early phase genes within the
first hour, including Tnf which was markedly reduced and Ccl20,
whose gene transcription was effectively abolished. The dynamics of
Tnfaip3 and Nfkbia transcription were similar in both genotypes,
but elevated in Il10 null enteroids. IL-10 appeared to be a negative
regulator of Tnfaip3 andNfkbia, both encoding known inhibitors of
NFkB (54, 55), as their expression levels were observed in our study
to be higher or sustained for a longer period in IL-10 deficient
enteroids compared to the wild-type cultures. With flagellin, we
observed enhanced transcription of Irf1 and Nfkbiz in IL-10 null
enteroids. This is perhaps not unexpected since the two receptors do
not share identical downstream signalling pathways, with TNFR1A
B
FIGURE 5 | TNF induces interleukin 10 expression and release from C57BL/
6J enteroids. Analysis of (A) Il10 mRNA (measured by qPCR) and (B) IL10
protein (measured by ELISA) in resting and 40 ng/ml TNF-treated enteroid
cultures from C57BL/6J mice. Significant differences compared to untreated
controls, *p < 0.05 and ***p < 0.001; Kruskal–Wallis test. Data is presented
as mean ± SEM; N = 6 mice.June 2021 | Volume 12 | Article 690817
Papoutsopoulou et al. Epithelial IL-10 Positively Regulates NFkBA
B
C
FIGURE 6 | IL-10 deficiency or IL-10R signaling blockade impacts on endogenous NFkB activation and downstream gene transcription in enteroids. (A) C57BL/6J
and Il10−/− enteroids were transduced with lentivirus that expresses luciferase under the control of canonical NFkB binding sequence motif. Post transduction (72 h),
enteroids were either left unstimulated or stimulated with 100 ng/ml TNF for 3 h. Luminescence was detected using single tube luminometer. (B) Immunoblockade of
hTNF.LucBAC enteroids using 1 mg/ml rat anti-mouse IL-10 receptor (IL-10R) antibody (Ab) or rat IgG1, k isotype control, followed by 2 h stimulation with 100 ng/ml
TNF. Significant differences to unstimulated control, *p < 0.05; or stimulated transgenic or immunoblockade, #p < 0.05, Kruskal–Wallis test; N = 3–4 mice).
(C) Immunoblockade using anti-IL-10R antibody also significantly suppressed TNF-induced expression at 1 h of two selected early response NFkB target genes
Tnf and Tnfaip3 in C57BL/6 enteroids. Significant differences, *p < 0.05 TNF plus IL-10R antibody compared to enteroids stimulated with TNF alone, and ##p < 0.01
compared to TNF plus isotype control antibody; Kruskal–Wallis test, N = 3 mice. All data is presented as mean ± SEM.Frontiers in Immunology | www.frontiersin.org June 2021 | Volume 12 | Article 69081712
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FIGURE 7 | The TNF-induced late response NFkB target gene Cxcl10 is dependent on IL-10/IL-10R signaling. Cxcl10 mRNA levels in enteroid cultures from
C57BL/6J and Il10−/− mice, (A) at rest, and (B) following treatment for 8 h with 40 ng/ml TNF. Significant differences of Il10 null enteroids compared to C57BL/6J
controls, **p < 0.01 and ***p < 0.001 (N=3-4 mice, Kruskal–Wallis test). (C) Assessment of Cxcl10 mRNA levels (as measured by qPCR) following overnight
immunoblockade with rat anti-mouse IL-10 receptor (IL-10R) antibody (Ab) or using rat IgG1, k isotype control, stimulated with 40 ng/ml TNF for 8 h. Significant
differences compared to enteroids stimulated with TNF alone as per Kruskal–Wallis test; *p < 0.05 and **p < 0.01. ns, no significant difference between TNF plus
anti-IL-10R and TNF plus isotype control antibody treatments (p = 0.18). All data presented as mean ± SEM; N = 3–4 mice.Frontiers in Immunology | www.frontiersin.org June 2021 | Volume 12 | Article 69081713
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associated factor 2 (TRAF2) pathway (71), and TLR5 signalling
utilising the MyD88 adaptor (83). As has been reported previously,
there are quantitative and gene-specific differences in responses
towards the two stimuli (84). For flagellin, our data support IL-10 as
exerting part of its anti-inflammatory function by negatively
regulating the levels of Irf1 in the intestinal epithelium. Irf1
regulates the expression of C–X–C motif chemokine 10 (Cxcl10),
that acts as a chemoattractant for immune cells and promotes
inflammation (69). Within our RNA sequencing dataset, we
observed Cxcl10 to be a TNF-induced late response NFkB target
gene, and its transcription was found to significantly suppressed in
IL-10 deficient enteroids. Cxcl10 expression is reported as being
localised mainly to epithelial cells in the intestinal mucosa, with
increased levels seen in IBD tissues (85), where mucosal levels of
pro-inflammatory TNF are also notably high (27). Although our in
vitro enteroid data contradict the anti-inflammatory role of IL-10 in
relation to Cxcl10 expression following TNF stimulation, further in
vitro and in vivo experiments are necessary in order to understand
the regulation of this late response gene. This is because there are
clear limitations of the enteroid model which do not represent the
complex interplay for immune and stromal cells that would be
found in vivo. Also, it is known that Cxcl10 transcription depends
on protein synthesis (86, 87) and on additional transcription factors,
such as activator protein 1 (AP-1) (87) and key transcriptional
repressors 4E-BP1/2 (88).
To further establish a role for epithelium-derived IL-10, we
examined for its expression in wild-type enteroids. We showed
early TNF-induced transcription of Il10, which was followed by
low levels of IL-10 protein detected in the enteroid culture
medium, at picogram levels similar to those previously
reported in small intestinal tissue from C57BL/10 mice (89).
We then monitored the activation of the NFkB pathway upon
TNF stimulation in the absence of IL-10 or immunoblockade of
the IL-10R. Utilising transduced and transgenic luciferase
reporter enteroids, our data clearly showed that IL-10 is a
positive regulator of epithelium-specific endogenous NFkB
activation. A key study supporting our data is that conducted
previously by Nenci and colleagues, where they demonstrated
that intestinal-specific ablation of the upstream kinases of the
canonical NFkB pathway resulted in development of
spontaneous, severe intestinal inflammation in mice (22).
These data clearly suggest the NFkB signalling pathway in the
gut epithelium as a critical regulator of epithelial integrity and
intestinal immune homeostasis (90). Anti-inflammatory
function of epithelial-derived IL10 through autocrine action
via the non-classical MHC molecule CD1d has also been
proposed in another recent study, where IL-10 is shown to
attenuate IFNg-induced intestinal epithelium damage (91). The
importance of IL-10 signalling on the maintenance and
restitution of intestinal epithelial barrier is further highlighted
in in vivo studies using IL-10 receptor deficient mice (92).
Moreover, IL-10 receptor point mutations have been linked to
inflammatory conditions, such as IBD (93, 94).
In summary, our study utilised ATAC and RNA sequencing
and in vitro enteroid culture approaches to study the (patho)Frontiers in Immunology | www.frontiersin.org 14physiological response of the intestinal epithelium to TNF. We
have shown that upon stimulation, the NFkB pathway is the
major transcriptional regulator of the intestinal epithelium.
Moreover, epithelium-derived IL-10 appears to play a crucial
autocrine role in positively regulating NFkB and therefore
supporting its function as a major regulator of intestinal
homeostasis. Dysregulation of such a potent cytokine could
potentially lead to a low level, chronic inflammation
underlying intestinal epithelial disease. We have recently
reported a recombinant stable IL-10 dimer that attenuates
bacterial lipopolysaccharide-induced dermal inflammation
(95), thus highlighting the potential for future tissue-targeted
IL-10 therapeutic intervention.DATA AVAILABILITY STATEMENT
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